Marcin R.
- Country
- Poland
- Department
- N/A
Research Overview
- Investigation of RO7121932 Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics in Multiple Sclerosis Patients
- Comparative Efficacy and Safety Study of CYB704 and Ocrelizumab in Relapsing Multiple Sclerosis Patients
- Phase 3 Randomized Double-Blind Study of Orelabrutinib for Primary Progressive Multiple Sclerosis in Patients With PPMS
Data & Insights
Has run more than one trial at 195 of 416 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in treating Alzheimer's Disease, with particular focus on early-stage interventions and novel therapeutic approaches. Their research encompasses various treatment modalities including experimental antibodies and innovative compounds targeting cognitive decline.
- Early-stage Alzheimer's Disease management
- Mild Cognitive Impairment (MCI)
- Clinical Dementia Rating assessments
Multiple Sclerosis
The investigator conducts extensive research in Multiple Sclerosis treatment, covering both progressive and relapsing forms of the disease. Their work includes evaluation of immunomodulatory therapies and assessment of disease progression markers.
- Primary Progressive Multiple Sclerosis (PPMS)
- Relapsing Multiple Sclerosis
- Brain atrophy measurement techniques
Other Neurological Conditions
The investigator's expertise extends to other neurological disorders, including Frontotemporal Dementia and Migraine. Their research involves innovative treatment approaches including gene therapy and preventive interventions.
- FTD with Progranulin Mutations
- Chronic and Episodic Migraine prevention
- Novel therapeutic delivery methods
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.